Kolexia
Dobi Erion
Oncologie médicale
Hôpital Jean-Minjoz
Besançon, France
113 Activités
1 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeurs colorectales Tumeurs du foie Tumeurs de la prostate Carcinomes Récidive tumorale locale Adénocarcinome Neutropénie

Industries

A+A
248 collaboration(s)
Dernière en 2023
B3TSI
242 collaboration(s)
Dernière en 2023
P\S\L Group Services
152 collaboration(s)
Dernière en 2023
IQVIA
70 collaboration(s)
Dernière en 2023

Dernières activités

477P Do ESR1-related mutations generate neoantigens in hormone-receptor-positive HER2-negative metastatic breast cancer?
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study.
BMC cancer   17 mai 2023
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab.
Frontiers in cardiovascular medicine   23 septembre 2022
HERibuline: Eribulin mesylate and Trastuzumab in pretreated HER2-positive advanced breast cancer—A report of region’s practice.
2022 ASCO Annual Meeting I   02 juin 2022
FATSOMCAN: Effects of a Supervised Exercise on Sleep in Patients With Non Metastatic Breast Cancer During Chemotherapy
Essai Clinique (CHU Besançon)   31 mai 2022
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.
Scientific reports   07 mars 2022
VICTORIANE: A Randomized Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Essai Clinique (Pierre Fabre)   29 janvier 2021
CARDAPAC: Impact of Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer, During Treatment With Trastuzumab in Adjuvant
Essai Clinique (Université de Franche-Comté)   05 octobre 2020
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer.
BMC cancer   01 novembre 2019
Prolonged overall survival for patients with bone-only metastases at presentation of metastatic breast cancer
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018